Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model?

Canadian Journal of Psychiatry

Volumn 62, Issue 2, 2017, Pages 115-122

  Duffy, Anne ^a,b   Malhi, Gin S ^c,d   Grof, Paul ^b,e  

^a UNIVERSITY OF CALGARY   (Canada)

^b Mood Disorders Centre of Ottawa   (Canada)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

biomarkers; bipolar disorder; clinical course; heterogeneity; mood disorders; prodromes; psychotic disorders; risk syndromes; staging

Indexed keywords

BIPOLAR DISORDER; DISEASE COURSE; FAMILY HISTORY; GENETIC HETEROGENEITY; HUMAN; NEUROBIOLOGY; RECURRENT DISEASE; REVIEW; SCHIZOPHRENIA; TREATMENT RESPONSE; DISEASE EXACERBATION; PATHOPHYSIOLOGY; PRODROMAL SYMPTOM;

BIPOLAR DISORDER; DISEASE PROGRESSION; HUMANS; PRODROMAL SYMPTOMS; SCHIZOPHRENIA;

EID: 85011593468     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/0706743716649189     Document Type: Review

References (101)

1. Duffy A, Carlson GA,. How does a developmental perspective inform us about the early natural history of bipolar disorder? J Can Acad Child Adolesc Psychiatry. 2013; 22: 6-12.
2. McGorry PD,. Early clinical phenotypes, clinical staging, and strategic biomarker research: building blocks for personalized psychiatry. Biol Psychiatry. 2013; 74: 394-395.
3. Berk M, Hallam K, Malhi GS, et al. Evidence and implications for early intervention in bipolar disorder. J Ment Health. 2010; 19: 113-126.
4. McGorry PD, Nelson B, Goldstone S, Yung AR,. Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can J Psychiatry. 2010; 55: 486-497.
5. Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, McCloskey S, Grof P,. The developmental trajectory of bipolar disorder. Br J Psychiatry. 2014; 204: 122-128.
6. Berk M, Conus P, Lucas N, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007; 9: 671-678.
7. Duffy A,. Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence. Can J Psychiatry. 2014; 59: 659-666.
8. Scott J, Leboyer M, Hickie I, et al. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry. 2013; 202: 243-245.
9. Fusar-Poli P, Yung AR, McGorry P, van Os J,. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med. 2014; 44: 17-24.
10. McGorry P, van Os J,. Redeeming diagnosis in psychiatry: timing versus specificity. Lancet. 2013; 381: 343-345.
11. McGorry P, Nelson B,. Why we need a transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment. JAMA Psychiatry. 2016; 73: 191-192.
12. Trede K, Salvatore P, Baethge C, Gerhard A, Maggini C, Baldessarini RJ,. Manic-depressive illness: evolution in Kraepelin's textbook, 1883-1926. Harvard Review of Psychiatry. 2005: 13: 155-178.
13. Grof P, Alda M, Ahrens B,. Clinical course of affective disorders: were Emil Kraepelin and Jules Angst wrong? Psychopathology. 1995; 28 (suppl 1): 73-80.
14. Craddock N, Owen MJ,. The Kraepelinian dichotomy-going, going... but still not gone. Br J Psychiatry. 2010; 196: 92-95.
15. Shorter E,. History of psychiatry. Curr Opin Psychiatry. 2008; 21: 593-597.
16. Malhi GS, Rosenberg DR, Gershon S,. Staging a protest! Bipolar Disord. 2014; 16: 776-779.
17. Ghaemi SN, Dalley S,. The bipolar spectrum: conceptions and misconceptions. Aust N Z J Psychiatry. 2014; 48: 314-324.
18. Kendler KS,. Kraepelin and the differential diagnosis of dementia praecox and manic-depressive insanity. Comp Psychiatry. 1986; 27: 549-558.
19. Angst J, Sellaro R,. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 2000; 48: 445-457.
20. Angst J GA,. Diagnosis and course of affective psychoses: was Kraepelin right? Eur Arch Psychiatry Clin Neurosci. 2008: 258 (suppl 2): 107-110.
21. Duffy A, Grof P,. Psychiatric diagnoses in the context of genetic studies of bipolar disorder. Bipolar Disord. 2001; 3: 270-275.
22. Grof P, Duffy A, Alda M, Hajek T,. Lithium response across generations. Acta Psychiatr Scand. 2009; 120: 378-385.
23. Amerio A, Odone A, Marchesi C, Ghaemi SN,. Is depression one thing or many? Br J Psychiatry. 2014; 204: 488.
24. Garnham J, Munro A, Slaney C, et al. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord. 2007; 104: 185-190.
25. Rice J, Reich T, Andreasen NC, et al. The familial transmission of bipolar illness. Arch Gen Psychiatry. 1987; 44: 441-447.
26. Evans L, Akiskal HS, Keck PE Jr, et al. Familiality of temperament in bipolar disorder: support for a genetic spectrum. J Affect Disord. 2005; 85: 153-168.
27. Winokur G, Tsuang MT, Crowe RR,. The Iowa 500: affective disorder in relatives of manic and depressed patients. Am J Psychiatry. 1982; 139: 209-212.
28. Blacker D, Lavori PW, Faraone SV, Tsuang MT,. Unipolar relatives in bipolar pedigrees: a search for indicators of underlying bipolarity. Am J Med Genet. 1993; 48: 192-199.
29. McGuffin P, Katz R,. The genetics of depression and manic-depressive disorder. Br J Psychiatry. 1989; 155: 294-304.
30. O'Donovan C, Garnham JS, Hajek T, Alda M,. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk. J Affect Disord. 2008; 107: 293-298.
31. Malhi GS, Masson M, Bellivier F,. Teasing apart Bipolar III: the causes and consequences of a Treatment-Emergent Affective Switch (TEAS) into mania. Aust N Z J Psychiatry. 2015; 49: 866-868.
32. Akiskal HS, Maser JD, Zeller PJ, et al. Switching from 'unipolar' to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry. 1995; 52: 114-123.
33. Deshauer D, Grof E, Alda M, Grof P,. Patterns of DST positivity in remitted affective disorders. Biol Psychiatry. 1999; 45: 1023-1029.
34. Lien YJ, Tsuang HC, Chiang A, et al. The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B: 1-9.
35. Baron M, Risch N,. The spectrum concept of schizophrenia: evidence for a genetic-environmental continuum. J Pychiatr Res. 1987; 21: 257-267.
36. Merikangas KR, Cui L, Heaton L, et al. Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Mol Psychiatry. 2014; 19: 214-219.
37. Vandeleur CL, Merikangas KR, Strippoli MP, Castelao E, Preisig M,. Specificity of psychosis, mania and major depression in a contemporary family study. Mol Psychiatry. 2014; 19: 209-213.
38. Malhi GS, Geddes JR,. Carving bipolarity using a lithium sword. Br J Psychiatry. 2014; 205: 337-339.
39. Grof P, Alda M, Grof E, Zvolsky P, Walsh M,. Lithium response and genetics of affective disorders. J Affect Disord. 1994; 32: 85-95.
40. Grof P, Duffy A, Cavazzoni P, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry. 2002; 63: 942-947.
41. Alda M,. The phenotypic spectra of bipolar disorder. Neuropsychopharmacology. 2004; 14: 94-99.
42. Hajek T, Cullis J, Novak T, et al. Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus. Biol Psychiatry. 2013; 73: 144-152.
43. Kruger S, Alda M, Young LT, Goldapple K, Parikh S, Mayberg HS,. Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry. 2006; 163: 257-264.
44. Hou L, Heilbronner U, Degenhardt F, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016; 387: 1085-1093.
45. Mertens J, Wang QW, Kim Y, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015; 527: 95-99.
46. Rosa AR, Magalhaes PV, Czepielewski L, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014; 75: e450-e456.
47. Cardoso T, Bauer IE, Meyer TD, Kapczinski F, Soares JC,. Neuroprogression and cognitive functioning in bipolar disorder: a systematic review. Curr Psychiatry Rep. 2015; 17: 75.
48. Kotov R, Leong SH, Mojtabai R, et al. Boundaries of schizoaffective disorder: revisiting Kraepelin. JAMA Psychiatry. 2013; 70: 1276-1286.
49. Malhi GS,. Making up schizoaffective disorder: cosmetic changes to a sad creation? Aust N Z J Psychiatry. 2013; 47: 891-894.
50. Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V,. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord. 2008; 10: 215-230.
51. Gershon ES, Alliey-Rodriguez N, Liu CY,. After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. Am J Psychiatry. 2011; 168: 253-256.
52. Lehrer DS, Pato MT, Nahhas RW, et al. Paternal age effect: replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis. Am J Med Genet B Neuropsychiatr Genet. 2015 Jul 16; Epub ahead of print.
53. Lee J, Altshuler L, Glahn DC, Miklowitz DJ, Ochsner K, Green MF,. Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am J Psychiatry. 2013; 170: 334-341.
54. Demjaha A, MacCabe JH, Murray RM,. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophrenia Bull. 2012; 38: 209-214.
55. Hajek T, Calkin C, Blagdon R, Slaney C, Uher R, Alda M,. Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders. Neuropsychopharmacology. 2014; 39: 2910-2918.
56. Pfennig A, Alda M, Young T, et al. Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplay. Int J Bipolar Disord. 2014; 2: 1.
57. Post RM,. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992; 149: 999-1010.
58. Grof P, Cakuls P, Dostal T,. Lithium dropouts: a follow-up study of patients who discontinued prophylactic treatment. Int Pharmacopsychiatry. 1970; 5: 162-169.
59. Schou M TK, Baastrup P,. Studies on the course of current endongeneous affective disorders. J Int Pharmacopsychiat. 1970; 5: 100-106.
60. Baethge C, Tondo L, Bratti IM, et al. Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry. 2003; 48: 449-457.
61. Bienvenu OJ, Davydow DS, Kendler KS,. Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence. Psychol Med. 2011; 41: 33-40.
62. Duffy A, Alda M, Kutcher S, Fusee C, Grof P,. Psychiatric symptoms and syndromes among adolescent children of parents with lithium-responsive or lithium-nonresponsive bipolar disorder. Am J Psychiatry. 1998; 155: 431-433.
63. Turecki G, Grof P, Grof E, et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry. 2001; 6: 570-578.
64. Duffy A,. The early natural history of bipolar disorder: what we have learned from longitudinal high-risk research. Can J Psychiatry. 2010; 55: 477-485.
65. Duffy A, Grof P, Hajek T, Alda M,. Resolving the discrepancy in childhood bipolar high-risk study findings. Am J Psychiatry. 2010; 167: 716.
66. Duffy A, Alda M, Hajek T, Sherry SB, Grof P,. Early stages in the development of bipolar disorder. J Affect Disord. 2010; 121: 127-135.
67. Duffy A,. Early identification of recurrent mood disorders in youth: the importance of a developmental approach. Evid Based Mental Health. 2015; 18: 7-9.
68. MacCabe JH, Murray RM,. Intellectual functioning in schizophrenia: a marker of neurodevelopmental damage? J Intellect Disabil Res. 2004; 48: 519-523.
69. MacCabe JH, Lambe MP, Cnattingius S, et al. Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study. Br J Psychiatry. 2010; 196: 109-115.
70. Cannon M, Caspi A, Moffitt TE, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002; 59: 449-456.
71. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C,. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res. 2004; 71: 405-416.
72. MacQueen GM, Grof P, Alda M, Marriott M, Young LT, Duffy A,. A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder. Bipolar Disord. 2004; 6: 374-378.
73. Duffy A, Hajek T, Alda M, Grof P, Milin R, MacQueen G,. Neurocognitive functioning in the early stages of bipolar disorder: visual backward masking performance in high risk subjects. Eur Arch Psychiatry Clin Neurosci. 2009; 259: 263-369.
74. Duffy A,. The nature of the association between childhood ADHD and the development of bipolar disorder: a review of prospective high-risk studies. Am J Psychiatry. 2012; 169: 1247-1255.
75. McGorry PD NB, Amminger GP, et al. Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009; 70: 1206-1212.
76. Wiltink S, Velthorst E, Nelson B, McGorry PM, Yung AR,. Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra-high-risk service. Early Interv Psychiatry. 2015; 9: 200-206.
77. Yung AR, Phillips LJ, Yuen HP, McGorry PD,. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004; 67: 131-142.
78. van der Gaag M, Smit F, Bechdolf A, et al. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res. 2013; 149: 56-62.
79. Fusar-Poli P, Cappucciati M, Borgwardt S, et al. Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry. 2016; 73: 113-120.
80. Berk M, Hallam KT, McGorry PD,. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord. 2007; 100: 279-281.
81. Conus P, McGorry PD,. First-episode mania: a neglected priority for early intervention. Aust N Z J Psychiatry. 2002; 36: 158-172.
82. Kessing LV, Vradi E, McIntyre RS, Andersen PK,. Causes of decreased life expectancy over the life span in bipolar disorder. J Affect Disord. 2015; 180: 142-147.
83. Ghaemi SN, Ko JY, Goodwin FK,. "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002; 47: 125-134.
84. Correll CU, Hauser M, Penzner JB, et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord. 2014; 16: 478-492.
85. Conus P, Ward J, Lucas N, et al. Characterisation of the prodrome to a first episode of psychotic mania: results of a retrospective study. J Affect Disord. 2010; 124: 341-345.
86. Conus P, Cotton S, Abdel-Baki A, Lambert M, Berk M, McGorry PD,. Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. Bipolar Disord. 2006; 8: 221-231.
87. Bechdolf A, Nelson B, Cotton SM, et al. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J Affect Disord. 2010; 127: 316-320.
88. Bechdolf A, Ratheesh A, Wood SJ, et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharmaceut Des. 2012; 18: 358-375.
89. Ruggero CJ, Carlson GA, Kotov R, Bromet EJ,. Ten-year diagnostic consistency of bipolar disorder in a first-admission sample. Bipolar Disord. 2010; 12: 21-31.
90. Carlson GA,. Diagnostic stability and bipolar disorder in youth. J Am Acad Child Adolesc Psychiatry. 2011; 50: 1202-1204.
91. Reichart CG, Wals M, Hillegers MH, Ormel J, Nolen WA, Verhulst FC,. Psychopathology in the adolescent offspring of bipolar parents. J Affect Disord. 2004; 78: 67-71.
92. Wals M, Hillegers MH, Reichart CG, Ormel J, Nolen WA, Verhulst FC,. Prevalence of psychopathology in children of a bipolar parent. J Am Acad Child Adolesc Psychiatry. 2001; 40: 1094-1102.
93. Mesman E, Nolen WA, Reichart CG, Wals M, Hillegers MH,. The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry. 2013; 170: 542-549.
94. Duffy A, Alda M, Hajek T, Grof P,. Early course of bipolar disorder in high-risk offspring: prospective study. Br J Psychiatry. 2009; 195: 457-458.
95. Axelson D, Goldstein B, Goldstein T, et al. Diagnostic precursors to bipolar disorder in offspring of parents with bipolar disorder: a longitudinal study. Am J Psychiatry. 2015; 172: 638-646.
96. Duffy A, Horrocks J, Milin R, Doucette S, Persson G, Grof P,. Adolescent substance use disorder during the early stages of bipolar disorder: a prospective high-risk study. J Affect Disord. 2012; 142: 57-64.
97. Malhi GS, Fritz K, Allwang C, et al. Are manic symptoms that 'dip' into depression the essence of mixed features? J Affect Disord. 2016; 192: 104-108.
98. Malhi GS, Fritz K, Allwang C, et al. Agitation for recognition by DSM-5 mixed features specifier signals fatigue? Aust N Z J Psychiatry. 2015; 49: 499-501.
99. Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R,. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry. 2003; 60: 709-717.
100. Cuthbert BN, Insel TR,. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013; 11: 126.
101. Nandy A, Gangopadhyay S, Mukhopadhyay A,. Individualizing breast cancer treatment: the dawn of personalized medicine. Exp Cell Res. 2014; 320: 1-11.